Cannabinoid and opioid interactions: implications for opiate dependence and withdrawal - Wikidata - thesis-toulmin - TriplyDB

Cannabinoid and opioid interactions: implications for opiate dependence and withdrawal

Cannabinoid and opioid interactions: implications for opiate dependence and withdrawal

http://www.wikidata.org/entity/Q27000762

about

Elevated Norepinephrine may be a Unifying Etiological Factor in the Abuse of a Broad Range of Substances: Alcohol, Nicotine, Marijuana, Heroin, Cocaine, and Caffeine Effect of Pharmacological Modulation of the Endocannabinoid System on Opiate Withdrawal: A Review of the Preclinical Animal Literature Pregabalin for the Treatment of Drug and Alcohol Withdrawal Symptoms: A Comprehensive Review Mice expressing a "hyper-sensitive" form of the CB1 cannabinoid receptor (CB1) show modestly enhanced alcohol preference and consumption.Impact of efficacy at the μ-opioid receptor on antinociceptive effects of combinations of μ-opioid receptor agonists and cannabinoid receptor agonists.Medical cannabis laws and opioid analgesic overdose mortality in the United States, 1999-2010 Genetic risk signatures of opioid-induced respiratory depression following pediatric tonsillectomy Differential effects of endocannabinoid catabolic inhibitors on morphine withdrawal in mice.Interactions of the opioid and cannabinoid systems in reward: Insights from knockout studies.Safety and pharmacokinetics of oral cannabidiol when administered concomitantly with intravenous fentanyl in humans Novel associations between FAAH genetic variants and postoperative central opioid-related adverse effects.The effects of dronabinol during detoxification and the initiation of treatment with extended release naltrexone.Naltrexone Maintenance Decreases Cannabis Self-Administration and Subjective Effects in Daily Cannabis Smokers.Safety of oral dronabinol during opioid withdrawal in humans Effects of daily delta-9-tetrahydrocannabinol treatment on heroin self-administration in rhesus monkeys.The newer Opioid Agonist Treatment with lower substitutive opiate doses is associated with better toxicology outcome than the older Harm Reduction Treatment.Combining rimonabant and fentanyl in a single entity: preparation and pharmacological results Novel Pharmacologic Approaches to Treating Cannabis Use Disorder.Neuroinflammation as a possible link between cannabinoids and addiction.New approaches in the design and development of cannabinoid receptor ligands: multifunctional and bivalent compounds.Therapies in early development for the treatment of opiate addiction.Preclinical Studies of Cannabinoid Reward, Treatments for Cannabis Use Disorder, and Addiction-Related Effects of Cannabinoid Exposure.The dynamic interaction between pain and opioid misuse.Monoglyceride lipase as a drug target: At the crossroads of arachidonic acid metabolism and endocannabinoid signaling.No evidence for reduction of opioid-withdrawal symptoms by cannabis smoking during a methadone dose taper.Concomitant cannabis abuse/dependence in patients treated with opioids for non-cancer pain.Interactions between the Kynurenine and the Endocannabinoid System with Special Emphasis on Migraine Opioid withdrawal suppression efficacy of oral dronabinol in opioid dependent humans.Fatty acid amide hydrolase-morphine interaction influences ventilatory response to hypercapnia and postoperative opioid outcomes in children.Exploring the first Rimonabant analog-opioid peptide hybrid compound, as bivalent ligand for CB1 and opioid receptors.Medical marijuana laws and adolescent use of marijuana and other substances: Alcohol, cigarettes, prescription drugs, and other illicit drugs.Impact of Medical Marijuana Laws on State-Level Marijuana Use by Age and Gender, 2004-2013.Can Naloxone Be Used to Treat Synthetic Cannabinoid Overdose?Accuracy of Patient Opioid Use Reporting at the Time of Medical Cannabis License Renewal.Evolution of patients' socio-behavioral characteristics in the context of DAA: Results from the French ANRS CO13 HEPAVIH cohort of HIV-HCV co-infected patients.Emerging Evidence for Cannabis' Role in Opioid Use Disorder

P2860

Q24608522-45CB7A0D-EA9E-4A91-A516-F256AE87633E Q26738333-C88A5F32-A681-48C6-83A4-ED7FEFA84AF0 Q28074617-2C16DCD3-5205-4D90-A1A2-CC8CA17805F5 Q33585822-C589FDC8-F272-47C8-9288-E26D32A2DF88 Q34360705-A15C8486-65E1-49A4-BE44-63EAE9D8ABAC Q34664106-1343329F-F5E1-4DB8-832A-731AB40188F3 Q34872670-5B3B3C7F-36E2-4FCE-B9BE-02FCBBD16A1A Q34973799-BDAB9314-B05B-4CEB-84B6-DB2A8C2A2544 Q35053193-DD53B318-8425-42F1-BBEB-94C41A279A80 Q35665889-23B84722-7B46-4CFB-A8EF-487D1CD5A198 Q35822991-B4504C8D-5CFE-4FFC-A4DF-49292C67B737 Q35952033-2D838B54-58F9-46E0-806F-476AED14220B Q36059911-25BD58A3-0286-44CF-8A79-878BF0AB87E9 Q36328458-7176CE7F-453F-4CDD-914D-BA39C1E29AEF Q36655914-C503514B-03F9-4D12-82C9-E0FD5D0E464A Q37442770-D08F1170-44DD-4235-A7CF-087643CEC565 Q37602963-732DB1CF-80A3-4E63-AE04-0990C6CCC37F Q38222436-D8979C88-88D2-4AB8-880C-E0C0E3AE6CE0 Q38278954-E3EDF0AC-8E16-41D6-A9C6-CC619EA1E395 Q38395251-C8488585-9E8C-4341-834D-5C9CCD79E18C Q38594606-1AEED7A4-279C-47E3-B517-97D5F7BE8908 Q38636791-E3EE506B-1013-4A27-B660-AA8FEA66E7CA Q38731968-71A0E73B-0E45-4E64-A56D-8EC595445CAF Q39141240-6464CDB3-9E28-4714-A7B2-B5C1B5EE86DA Q41110701-F1C32334-B847-4411-8102-3802224C41A4 Q41511487-61D249B2-FB9B-4569-B40C-461A3D11D1D7 Q41572995-ECBEBA47-8648-4022-A58B-FB92DDC1D725 Q41810036-A1157320-7DF9-47C1-94E6-F37E337A20BD Q44341989-C13B70ED-57B9-4F6D-845C-536694094845 Q44342705-0446E45C-9C32-4CF5-9DD3-36378C9E2F5B Q46638742-32FDFB8F-A4A6-47F8-87C2-B54D4584B60D Q47657828-0A171404-96F9-47A7-860C-6D2D2049F570 Q47907390-E4BDB62C-8B5C-491D-8186-4ACFDCA4D9C0 Q52603583-F0BC69C3-D902-4990-B053-1DFC280CB308 Q55717379-110BFC1F-99AB-4085-A4A1-DEFBA55544A8 Q58775143-96BEDD8F-CCDE-419A-A1B9-0BA094D9247A

P2860

Cannabinoid and opioid interactions: implications for opiate dependence and withdrawal

http://www.wikidata.org/entity/Q27000762

description

2013 nî lūn-bûn

@nan

2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Cannabinoid and opioid interactions: implications for opiate dependence and withdrawal

@ast

Cannabinoid and opioid interactions: implications for opiate dependence and withdrawal

@en

Cannabinoid and opioid interactions: implications for opiate dependence and withdrawal

@nl

type

label

Cannabinoid and opioid interactions: implications for opiate dependence and withdrawal

@ast

Cannabinoid and opioid interactions: implications for opiate dependence and withdrawal

@en

Cannabinoid and opioid interactions: implications for opiate dependence and withdrawal

@nl

prefLabel

Cannabinoid and opioid interactions: implications for opiate dependence and withdrawal

@ast

Cannabinoid and opioid interactions: implications for opiate dependence and withdrawal

@en

Cannabinoid and opioid interactions: implications for opiate dependence and withdrawal

@nl

P1433

Q27000762-860851E4-189A-4777-AAEB-BA4DF552573C

P1476

Q27000762-2CF8F1FB-34F6-4717-A128-571EF597CCA1

P2093

Q27000762-26D9802A-6388-4B52-AE76-0577D4F21625

Q27000762-4B3E0554-E8C6-42F8-A058-8FC9567FD6B9

Q27000762-81109885-4FED-46A6-9D22-EA18B5BBD059

P2860

Q27000762-00197A95-976C-4528-AB33-0798F4439EEE

Q27000762-00F08900-0B83-4304-B0BB-9EA131A8DAEC

Q27000762-014CF8FC-ECDD-4828-8E6F-0DED452C62E9

Q27000762-0335D5A1-4167-4410-8F2A-FB9BD5519E90

Q27000762-06CE4ED5-5F7F-4B41-AD47-3E6CF57695B0

Q27000762-0A016E2D-9520-4510-8484-8197CC3B6BE9

Q27000762-0AD2FBE1-7840-453E-A50A-09361938D8A3

Q27000762-0BD424D2-D024-4EDB-BBBB-3C9C532B4163

Q27000762-0C2D5274-4E55-4942-83FC-6F01958E9A36

Q27000762-0E60864F-80CF-45E1-AAD1-1189CBCE0693

P304

Q27000762-CDE6EE99-2AA5-4798-A51B-79A9B6D789A8

P31

Q27000762-A96C2EFD-1754-4D95-99F6-6D8890CABADB

P3181

Q27000762-9EAAAAE7-FA7D-4F32-A96C-B6E1B9417F23

P356

Q27000762-2DB67B9E-C4B4-4D5D-8F9C-1EAEDA4A57C0

P407

Q27000762-9B09A73E-F775-4839-A22F-177B5D3335B9

P478

Q27000762-49FC1700-2450-4795-A614-603826EB4CAD

P577

Q27000762-2BA55941-6638-438E-9ED4-0DFDD32B9ED7

P698

Q27000762-B7C67FF2-F632-447D-84F4-AC480C900559

P921

Q27000762-0DCD003E-5C5C-4158-99BE-3BE78C6C5465

Q27000762-9a8aefe5-2a62-4a61-8df9-bb9954fb5b72

P932

Q27000762-2D3E3467-4497-4E45-A8D0-6F22B9297503

P3181

P356

J.NEUROSCIENCE.2013.04.034

P1433

P1476

Cannabinoid and opioid interactions: implications for opiate dependence and withdrawal

@en

P2093

E.J. Van Bockstaele

http://www.w3.org/2001/XMLSchema#string

J.L. Scavone

http://www.w3.org/2001/XMLSchema#string

R.C. Sterling

http://www.w3.org/2001/XMLSchema#string

P2860

Alpha2 adrenergic agonists for the management of opioid withdrawal

Intermittent marijuana use is associated with improved retention in naltrexone treatment for opiate-dependence

Role of endogenous cannabinoids in synaptic signaling

A second endogenous cannabinoid that modulates long-term potentiation

Cannabinoid signalling

Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants

2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain

Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors

Correlation between the in vivo and an in vitro expression of opiate withdrawal precipitated by naloxone: their antagonism by l-(-)-delta9-tetrahydrocannabinol

Reduction of opioid dependence by the CB(1) antagonist SR141716A in mice: evaluation of the interest in pharmacotherapy of opioid addiction

P304

637-54

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

468139

http://www.w3.org/2001/XMLSchema#string

P356

10.1016/J.NEUROSCIENCE.2013.04.034

http://www.w3.org/2001/XMLSchema#string

P407

P478

248

http://www.w3.org/2001/XMLSchema#string

P577

2013-09-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23624062

http://www.w3.org/2001/XMLSchema#string

P921

P932

3742578

http://www.w3.org/2001/XMLSchema#string